Pulmonology Lasers Market Report 2026

Pulmonology Lasers Market Overview

• Pulmonology Lasers market size has reached to $5.52 billion in 2025 • Expected to grow to $8.36 billion in 2030 at a compound annual growth rate (CAGR) of 8.5% • Growth Driver: Chronic Respiratory Diseases Propels Growth Of The Pulmonology Laser Market • North America was the largest region in 2025.

What Is Covered Under Pulmonology Lasers Market?

Pulmonology lasers are specialized medical devices used in the treatment of various respiratory conditions, for diagnostic and therapeutic purposes. These lasers emit high-energy light beams that can precisely target and vaporize abnormal or diseased tissue in the lungs. The purpose of pulmonology lasers is to provide minimally invasive treatment options for respiratory diseases, reducing the need for traditional surgery and improving patient outcomes. The main types of pulmonology lasers are neodymium-doped yttrium aluminum garnet (Nd-YAG) and photodynamic. Neodymium-doped yttrium aluminum garnet (Nd-YAG) is a crystal used in lasers for its ability to emit powerful infrared light. It is used for indications such as bronchogenic carcinoma, malignant lesions, benign tumors, neoplasms, hemorrhage, and tracheal stenosis. End users include specialty care centers, hospitals, academic centers, and research organizations.

What Is The Pulmonology Lasers Market Growth Forecast?

The pulmonology lasers market size is expected to see strong growth in the next few years. It will grow to $8.36 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing preference for minimally invasive respiratory treatments, growing investments in advanced interventional pulmonology tools, rising adoption of laser-based tumor management, expansion of specialty respiratory care centers, technological improvements in laser precision and control. Major trends in the forecast period include increasing adoption of minimally invasive laser therapies, rising use of nd-yag lasers in airway interventions, growing demand for precision tissue ablation, expansion of photodynamic laser applications, enhanced focus on procedure safety and accuracy.

Global Pulmonology Lasers Market Segmentation

1) By Type: Neodymium-Doped Yttrium Aluminum Garnet (Nd-YAG Laser), Photodynamic Laser 2) By Indication: Bronchogenic Carcinoma, Malignant Lesions, Benign Tumors, Neoplasms, Hemorrhage, Tracheal Stenosis 3) By End-Users: Specialty Care Centers, Hospitals, Academic Centers, Research Organizations Subsegments: 1) By Nd-YAG Laser: Continuous Wave Nd-YAG Laser, Pulsed Nd-YAG Laser 2) By Photodynamic Laser: Low-Level Photodynamic Laser, High-Intensity Photodynamic Laser

What Are The Drivers Of The Pulmonology Lasers Market?

The surge in chronic respiratory diseases is expected to propel the growth of the pulmonology laser market going forward. Chronic respiratory diseases encompass long-term conditions that affect the airways and lung structures, leading to breathing difficulties and substantially impacting quality of life. The rise in chronic respiratory diseases is due to factors such as air pollution, smoking, an aging population, rapid urbanization, and climate changes. Pulmonology lasers are used in chronic respiratory diseases for diagnostic bronchoscopy and therapeutic interventions such as treating airway obstructions or tumors. For instance, in December 2023, according to a research study published by JAMA Network Open, a medical journal by the American Medical Association, the global burden of chronic obstructive pulmonary disease (COPD) projected that the cases worldwide could reach nearly 600 million by 2050, marking a 23% increase in prevalence. Therefore, the surge in chronic respiratory diseases is driving the growth of the pulmonology laser industry. The increasing adoption of minimally invasive surgeries is expected to propel the growth of the pulmonology lasers market going forward. Invasive surgeries are medical procedures that involve entering the body, usually by making incisions, to treat or diagnose medical conditions. The increasing adoption of minimally invasive surgeries (MIS) is driven by key advantages such as reduced recovery time and hospital stays, lower risk of complications, less pain and scarring, and enhanced precision through advanced technology. The increasing adoption of minimally invasive surgeries (MIS) benefits the pulmonology lasers market by reducing trauma, enhancing precision, driving demand for advanced technologies, and expanding use in bronchoscopic and thoracoscopic procedures. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, minimally invasive procedures increased by 7% in 2023, outpacing the growth rate of surgical procedures by 2%. Hand surgeries such as carpal tunnel, arthritis, and trigger finger totaled 207,887 procedures, a 2% rise from 2022. Therefore, the rising adoption of minimally invasive surgeries is driving the growth of the pulmonology lasers industry. The growing geriatric population is expected to propel the growth of the pulmonology lasers market moving forward. The geriatric population refers to older adults, typically aged 65 years and above, who often require specialized healthcare and support due to age-related physiological changes. The growing geriatric population is primarily due to increasing life expectancy, which allows people to live longer, and declining birth rates, which reduce the proportion of younger individuals in the population. Pulmonology Lasers support the geriatric population by providing precise, minimally invasive treatments that improve respiratory function, reduce procedural risks, and enhance overall quality of life for older patients. For instance, in July 2024, according to the UK Parliament's House of Commons Library, a UK-based government administration, in 2022, there were 12.7 million people aged 65 or older in the UK, representing 19% of the total population. This number is projected to rise to 22.1 million by 2072, accounting for 27% of the population. Therefore, the growing geriatric population is driving the growth of the pulmonology lasers industry.

Key Players In The Global Pulmonology Lasers Market

Major companies operating in the pulmonology lasers market are Coherent Corp., IPG Photonics Corporation, Han's Laser Technology Industry Group, Lumenis Ltd, Biolitec AG, Ellex Medical Pty Ltd, Fotona LLC, Spectra-Physics Inc., Lumibird SA, EKSPLA Co, Optotek Medical, Optogama UAB, Beijing Hoplaser Lead-Edge Laser Techno. Ltd, Amada Miyachi, Richard Wolf GmbH, Karl Storz SE And Co. KG, Olympus Medical Systems Corp., Boston Scientific Corporation, Dornier MedTech, Asclepion Laser Technologies GmbH

Regional Outlook

North America was the largest region in the pulmonology lasers market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Pulmonology Lasers Market?

The pulmonology lasers market consists of sales of laser systems, laser fibers and probes, protective eyewear, smoke evacuators, and disposable components. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.